Skip to main content

Table 3 Estimated nonparametric relative effects showing intergroup differences as probabilities

From: Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation

 

Smoking controls omitted

Smoking controls included

 

FEV1

Non-activated neutrophils

NET-forming neutrophils

NETs

NET covered area

FEV1

Non-activated neutrophils

NET-forming neutrophils

NETs

NET covered area

Exacerbated COPD

0.27908

0.52941

0.56471

0.72680

0.75098

0.20931

0.53676

0.56225

0.75686

0.79363

Stable COPD

0.41690

0.45798

0.50280

0.49020

0.47479

0.31968

0.46534

0.50035

0.53081

0.52276

Smoking controls

     

0.76254

0.47794

0.50735

0.38408

0.36808

non-smoking controls

0.83725

0.52941

0.43137

0.28693

0.28431

0.74559

0.53676

0.42892

0.33137

0.32402

COPD grades 3/4

0.27669

0.51089

0.56100

0.64670

0.64089

0.20752

0.51825

0.55855

0.68192

0.68818

COPD grades 1/2

0.60784

0.41830

0.43137

0.41503

0.43682

0.47222

0.42565

0.42892

0.45425

0.47794

Smokong controls

     

0.76254

0.47794

0.50735

0.38408

0.36808

Non-smoking controls

0.83725

0.52941

0.43137

0.28693

0.28431

0.74559

0.53676

0.42892

0.33137

0.32402

  1. Evaluation of study data with a closed testing procedure performing multiple hypothesis tests simultaneously, significant endpoints in bold. Summary of estimated nonparametric relative effects of tested variables with and without inclusion of the smoking controls. Estimated relative effects measure the probability that a value obtained from one experimental group is larger than a value randomly chosen from the whole trial including the controls. The procedure yields similar conclusions about the significance of differences between study groups and between COPD severity groups, irrespective of whether smoking controls are excluded or included